Gemigliptin Tartrate (911637-19-9 free base)
Gemigliptin Tartrate (LC15-0444 tartrate) is a potent, selective, and competitive DPP-4 inhibitor with an IC50 of 10.3 nM. It is utilized in diabetes research for its anti-hyperglycemic and anti-glycation effects, as demonstrated in both in vitro enzymatic assays and in vivo metabolic disease models.
Product Specifications
CAS Number
1374639-74-3
Product Name Alternative
Inhibit, Inhibitor, Gemigliptin, Gemigliptin Tartrate (911637 19 9 free base), Gemigliptin Tartrate (911637199 free base), Gemigliptin Tartrate (911637-19-9 free base), LC15-0444, LC15-0444 tartrate, LC15-0444 Tartrate, mellitus, glycation, end, advanced, AGE, DPP4, DPP-4, DPP, diabetes, Dipeptidyl Peptidase, dipeptidyl, type, peptidase-4, products
Field of Research
Pharmacology & Drug Discovery, Protein Biochemistry
Purity
>99.99% (May vary between batches)
Solubility
DMSO:90 mg/mL (140.75 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (5.16 mM)
Smiles
O[C@H] ([C@@H] (O) C (O) =O) C (O) =O.N[C@H] (CN1CC (F) (F) CCC1=O) CC (=O) N1CCc2c (C1) nc (nc2C (F) (F) F) C (F) (F) F
Molecular Formula
C22H25F8N5O8
Molecular Weight
639.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402853-100 1x 100 µL
CD54 / ICAM-1 (15.2), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402823-100 1x 100 µL
BMI1 (Oncogene and Stem Cell Marker) (BMI1/2823), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details